Claire Stawnyczy


Lophos Pharmaceuticals Corp.

Claire is the CEO of Lophos Pharmaceuticals Corp., a psychedelic biosciences company focused on exploring Peyote derivatives, and has a strong scientific and regulatory background. She studied Cell & Molecular Biology and Industrial Biotechnology, then gained substantial experience working in large-scale cell culture fermentation, protein purification, and pharmaceutical manufacturing. Claire is also a co-founder of Canalytica Corp., a cannabis industry business management and regulatory consulting firm. From her experience working in the cannabis industry, Claire has worked with over 20 licensed producers, leading cannabis process validation for EU-GMP, and Health Canada licensing from initial application submissions to audit response, and regulated product development.